NTHI NEONC TECHNOLOGIES HOLDINGS...

Nasdaq neonctech.com


$ 6.21 $ -0.70 (-10.13 %)    

Thursday, 20-Nov-2025 12:49:08 EST
QQQ $ 592.42 $ -19.26 (-3.15 %)
DIA $ 459.52 $ -7.16 (-1.53 %)
SPY $ 657.95 $ -14.96 (-2.22 %)
TLT $ 89.21 $ 0.22 (0.25 %)
GLD $ 374.09 $ -1.06 (-0.28 %)
$ 6.73
$ 6.93
$ 6.20 x 100
$ 6.38 x 100
$ 6.21 - $ 6.94
$ 3.20 - $ 25.00
46,842
na
129.3M
$ -0.31
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2025 09-30-2025 10-Q
2 08-18-2025 06-30-2025 10-Q
3 05-09-2025 03-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
NeOnc Technologies Q3 EPS $(0.45)
11/14/2025 21:04:54

Core News & Articles

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biop...

Core News & Articles

NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi–Phase 2 clinical-stage biopharmace...

Core News & Articles

NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmace...

Core News & Articles

NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmace...

Core News & Articles

NeOnc Technologies Holdings, Inc. (NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biopharmace...

Core News & Articles

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) ("NeOnc" or the "Company"), a multi-Phase 2 clinical-stage biop...

Core News & Articles

NeOnc Technologies (NASDAQ:NTHI) reported quarterly losses of $(0.30) per share. This is a 11.11 percent decrease over losses o...

Core News & Articles

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi–Phase 2 clinical-stage biotechnology company pioneering therapies for ...

Core News & Articles

NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI), a multi–Phase 2 clinical-stage biotechnology company focused on breakthrough t...

Core News & Articles

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION